With reference to the circulars issued by BSE vide Circular no. LIST/COMP/01/2019-20 and NSE vide Circular no. NSE/CML/2019/11 dated April 2, 2019 pertaining to clarification regarding trading restriction period. In complying with the aforesaid circulars and pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, Bliss GVS Pharma has informed that the Trading window for dealing in securities/shares of the Company will remain closed for all the Designated Persons and their immediate relatives of the Company with immediate effect (i.e. April 4, 2019) until 48 hours after the announcement of the financial results of the Company for the quarter and financial year ended March 31, 2019.
The above information is a part of company’s filings submitted to BSE.
